Dr. Anugya Poudel-Chataut, MD

Dr. Poudel-Chataut practices at Ascension St. Vincent's Southside Hospital in Jacksonville, Florida, part of Ascension Health Alliance.

Dr. Poudel-Chataut's NPI, 1215244108, was assigned on September 13, 2010. Dr. Poudel-Chataut graduated from Indira Gandhi Medical College in 2006. Dr. Poudel-Chataut holds Florida license ME111926.

Dr. Poudel-Chataut's primary practice is Ascension St. Vincent's Southside Hospital, at 4201 Belfort Rd, Jacksonville, FL 32216 in Duval County. The practice phone is (904) 296-3700.

Dr. Poudel-Chataut's primary practice is Ascension St. Vincent's Southside Hospital in Jacksonville, Florida, part of Ascension Health Alliance. Dr. Poudel-Chataut is also affiliated with Baptist Medical Center Jacksonville. The medical group on file is UF Health Physicians. Dmand AI also links Dr. Poudel-Chataut to 4 more hospitals, 4 medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Poudel-Chataut practices, 7 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Poudel-Chataut's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Poudel-Chataut is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Poudel-Chataut's licenses on file in 2 states: Florida and Illinois.

Dmand AI lists anemia, cardiac arrhythmia, cellulitis, circulatory problems in extremities, heart attack, kidney failure, pneumonia and respiratory infection and sepsis among the conditions Dr. Poudel-Chataut treats.

CMS data shows 492 Medicare services from Dr. Poudel-Chataut across 4 procedure codes in 2024, for 243 Medicare patients. Medicare paid $38,433 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 243 Medicare patients who saw Dr. Poudel-Chataut in 2024. The largest group is 75 to 84, with 97 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 25% are also on Medicaid. Their average risk score is 2.78, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Poudel-Chataut's median patient age at 76, with 55% women.

In 2024, Dr. Poudel-Chataut wrote 282 Medicare Part D claims for 129 patients. 90% of them were for generic drugs. CMS names the drug for 102 of them, across 6 drugs with 11 or more claims each, at $5,906 in total drug cost. In 2023, CMS named 22 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 95 out of 100 for Dr. Poudel-Chataut for performance year 2024, reported through an alternative payment model (APM). Dr. Poudel-Chataut accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 4 general payments to Dr. Poudel-Chataut from 4 drug and device companies from 2018 to 2022. Food and beverage make up the largest share, 100% of the total. Novartis Pharmaceuticals Corporation paid the most, $112.

Dmand AI lists 1 award for Dr. Poudel-Chataut, most recently CMS Stage 1 EHR in 2013.

Dr. Poudel-Chataut graduated from Indira Gandhi Medical College in 2006.

Dr. Poudel-Chataut is in network with 3 carriers, including Excellus BlueCross BlueShield, CMS Medicare and GA State Medicaid. Medicare plans come from the most carriers, 2. Check the plan with the practice before a visit.